I appreciate the opportunity to be able to present a company update on Ideal Power to you. My name is David Somo, President and CEO of Ideal Power. As many of you know, I joined the company in ...
Texas Instruments is developing GaN power devices to enable more compact and efficient motor joints for humanoid robots.
The Polish offshore wind market has moved decisively from blueprint to execution. Phase I offshore wind projects are now ...
Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of ...
Kymera Therapeutics (NASDAQ:KYMR) used its fourth-quarter 2025 update call to highlight what management described as a “breakout year” driven by clinical progress for its oral STAT6 degrader KT-621, ...
Year Ended December 31, 2025NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today ...
The VOx619A series phototransistor optocouplers from Vishay Intertechnology, Inc. combine a high and linear current transfer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results